Moreland Mary K, of Abbott Laboratories (NYSE:ABT), sold 3,500 shares of company stock on November 05, 2026, according to a Form 4 filing with the Securities and Exchange…
At publication ·
Abbott Laboratories (NYSE:ABT) · insider sell
At a glance
Moreland Mary K, of Abbott Laboratories (NYSE:ABT), sold 3,500 shares of company stock on November 05, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
The shares were sold at an average price of $116.00 per share, for a total transaction value of $406.0K. Following this transaction, Moreland Mary K still owns 100,791 shares of Abbott Laboratories stock.
Abbott Laboratories's stock currently trades at $109.93, giving the company a market capitalization of $202.5B.
Insider sales are common and don't necessarily indicate a bearish outlook. Executives regularly sell shares for tax planning, diversification, or personal liquidity. The key factors to watch are the size of the sale relative to the insider's total holdings, whether multiple insiders are selling simultaneously, and whether the trades occur near earnings announcements or other catalysts.
This $406K transaction is a notable data point for investors tracking insider sentiment at Abbott Laboratories. While any single trade should be viewed in context, patterns of insider activity over time can provide valuable directional signals.
Insider transaction data is reported to the SEC via Form 4 filings, typically within two business days of the trade. Investors can track insider activity alongside other metrics — such as institutional flows, short interest, and technical indicators — to build a more complete picture of market sentiment around Abbott Laboratories.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 05, 2026 | Moreland Mary K | Sell | 3,500 | $406K |
| Sep 30, 2026 | Gonzalez Patricia Paola | Buy | 333 | $33K |
| Sep 30, 2026 | Ahuja Nita | Buy | 318 | $31K |
| Sep 30, 2026 | Roman Michael F | Buy | 381 | $38K |
| Sep 30, 2026 | Stratton John G | Buy | 397 | $39K |
Related Tools: Insider Trades Tracker | View ABT Stock Page
Insider insider_sells at Abbott Laboratories (NYSE:ABT) are reported to the SEC via Form 4 filings. While a single transaction doesn't predict future stock performance, patterns of insider buying can signal management confidence.
Monitor all insider transactions on the ABT insider trades page or the Insider Trades Tracker.
Current market data
NYSE · ABT
$110.51
Up: +$0.60 · +0.55%
Live quote updated
Keep reading
